查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1974464

第三方物流市场分析及预测（至2035年）：医疗保健产业，依类型、产品类型、服务、技术、组件、应用、部署类型、最终用户及解决方案划分

Healthcare Third-party Logistics Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Deployment, End User, Solutions
出版日期: | 出版商: Global Insight Services | 英文 426 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计医疗保健第三方物流市场规模将从2024年的2,346亿美元成长到2034年的4,924亿美元，复合年增长率约为7.7%。该市场涵盖医疗保健行业的专业外包物流服务，例如药品、医疗设备和医疗设备的运输、仓储和配送。推动市场成长的因素包括对成本效益、合规性以及日益复杂的全球供应链的需求。由于医疗保健产业对交付的准确性和可靠性要求极高，因此低温运输物流、即时追踪和库存管理技术的进步至关重要。

医疗保健产业的第三方物流市场面临复杂的环境，受到全球关税、地缘政治风险和不断变化的供应链动态的影响。在日本和韩国，企业正在增加对弹性供应链策略的投资，以减轻关税和地缘政治不确定性的影响。中国正加强自给自足，并推动国内物流能力的发展，以减少对外国公司的依赖。台湾凭藉其战略位置和物流专长占据重要地位，但仍易受地区紧张局势的影响。在技​​术创新和对高效医疗服务日益增长的需求的推动下，医疗保健物流行业正经历着强劲的全球成长。预计到2035年，该市场将朝着数位化整合和永续性的方向发展。中东衝突正对全球能源价格带来压力，间接影响物流成本和营运稳定性。

市场区隔
类型 低温运输物流，非低温运输物流
产品 药品、医疗设备、生物製药、疫苗、临床试验药物、非处方药及营养补充剂
服务 运输、仓储、库存管理、订单处理、包装、清关、逆向物流
科技 自动化仓库系统、仓库管理系统、运输管理系统、区块链、物联网、人工智慧与机器学习、机器人技术
成分 硬体、软体、服务
应用 医院、製药公司、生物製药公司、临床研究机构
实施表格 本机部署、云端部署、混合式部署
最终用户 医疗保健机构、製药企业、生技公司和物流公司
解决方案 供应链优化、库存视觉性、风险管理、合规管理

受医疗保健产业对高效供应链解决方案日益增长的需求所推动，第三方物流市场在医疗保健领域正经历显着成长。运输服务在整体绩效中发挥主导作用，其中温控物流和专业货运服务对于维持产品品质至关重要。尤其值得一提的是，由于生技药品和疫苗需求不断增长，低温运输物流在该领域的重要性日益凸显。

仓储领域也紧随其后，凸显了安全合规的医疗产品仓储设施的重要性。包括自动化仓储系统在内的先进仓储解决方案因其能够提升营运效率而备受关注。包装、贴标和库存管理等附加价值服务也逐渐成为关键要素，反映市场正向综合物流解决方案转型。

物联网和区块链等数位技术的整合正在变革物流运营，带来即时追踪和更高的透明度。这项技术进步有望进一步推动市场成长。

在医疗第三方物流市场，主要参与者正透过策略定价和创新产品推出争夺主导，导致市场份额动态变化。竞争格局的特点是注重成本效益和提升服务品质。各公司不断推出新产品，以满足医疗服务提供者不断变化的需求。这一趋势的驱动力在于，市场对能够确保医疗产品及时安全交付的精简物流解决方案的需求日益增长。各公司采取的定价策略对于维持竞争优势至关重要。

竞争标竿研究揭示了竞争异常激烈的市场环境，主要参与者正透过併购不断增强自身实力。监管影响也至关重要，因为严格遵守医疗保健法规是强制性的。这种合规性会影响新参与企业的商业策略和市场准入。数据驱动的分析凸显了物流产业数位转型日益增长的趋势，而技术应用已成为关键的差异化因素。供应链管理的创新以及物联网和人工智慧等先进技术的整合正在推动市场成长。

主要趋势和驱动因素：

受供应链日益复杂化和医疗服务全球化的推动，医疗保健领域的第三方物流市场正经历强劲成长。尤其值得关注的是，市场对温控物流的需求不断增长，这对于维持药品和生技药品的疗效至关重要。这一趋势凸显了先进低温运输解决方案的重要性，这些方案能够确保产品从生产到使用的整个过程的完整性。

此外，物联网和区块链等技术创新正在变革物流运营，提高透明度和可追溯性。这些创新技术能够实现即时监控，并降低仿冒品和违规的风险。另一个驱动因素是对成本效益和营运优化的日益重视。医疗服务提供者越来越多地将物流营运外包给第三方专业机构，以便专注于核心服务和提升患者照护。

此外，区域法规的复杂性要求企业采用专业的物流解决方案，因此企业纷纷寻求拥有全球专业知识的第三方物流合作伙伴。医疗保健领域电子商务的兴起也是一个显着趋势，消费者期望医疗用品和医疗设备能够更快地送达。对于能够提供满足医疗产业多方面需求的综合服务的物流供应商而言，存在着许多机会。随着市场的发展，那些能够创新并适应这些趋势的企业将获得竞争优势。

压制与挑战：

医疗保健产业的第三方物流市场面临许多重大限制和挑战。其中一个主要挑战是严格的法规环境，这要求遵守各种国际标准，并可能使营运变得复杂。此外，对温度敏感型药品的低温运输物流维护高成本，对第三方物流供应商带来了沉重的财务负担。同时，能够有效率地管理复杂医疗物流的熟练劳动力短缺也是限制市场发展的另一个因素。另一个挑战是日益严峻的网路安全威胁，这些威胁危及高度敏感医疗资料的完整性和保密性。最后，不断发展的医疗技术需要持续的调整和投资，这可能会造成资源紧张，并阻碍市场的快速反应。这些因素共同构成了重大障碍，影响着市场的成长潜力和营运效率。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制因素
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章：细分市场分析

  • 市场规模及预测：依类型
    • 低温运输物流
    • 非低温运输物流
  • 市场规模及预测：依产品划分
    • 製药
    • 医疗设备
    • 生物製药
    • 疫苗
    • 临床试验药物
    • 非处方药
    • 营养保健品
  • 市场规模及预测：依服务划分
    • 运输
    • 仓储
    • 库存管理
    • 订单履行
    • 包装
    • 报关
    • 逆向物流
  • 市场规模及预测：依技术划分
    • 自动化仓库系统
    • 仓库管理系统
    • 运输管理系统
    • 区块链
    • IoT
    • 人工智慧（AI）和机器学习
    • 机器人技术
  • 市场规模及预测：依组件划分
    • 硬体
    • 软体
    • 服务
  • 市场规模及预测：依应用领域划分
    • 医院
    • 製药公司
    • 生物製药公司
    • 临床研究机构
  • 市场规模及预测：依发展状况
    • 本地部署
    • 基于云端的
    • 杂交种
  • 市场规模及预测：依最终用户划分
    • 医疗保健提供者
    • 製药公司
    • 生技公司
    • 物流公司
  • 市场规模及预测：按解决方案划分
    • 供应链优化
    • 库存可见性
    • 风险管理
    • 合规管理

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 供需差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 监管概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章：公司简介

  • Kuehne Nagel
  • DHL Supply Chain
  • CEVA Logistics
  • UPS Healthcare
  • DB Schenker
  • GEODIS
  • FedEx Supply Chain
  • Nippon Express
  • Agility Logistics
  • Panalpina
  • Expeditors International
  • XPO Logistics
  • Sinotrans
  • DSV
  • Yusen Logistics
  • Rhenus Logistics
  • Bollore Logistics
  • Kintetsu World Express
  • Hellmann Worldwide Logistics
  • GEFCO

第九章：关于我们

简介目录
Product Code: GIS33135

Healthcare Third-party Logistics Market is anticipated to expand from $234.6 Billion in 2024 to $492.4 Billion by 2034, growing at a CAGR of approximately 7.7%. The Healthcare Third-party Logistics Market encompasses outsourced logistics services tailored for the healthcare sector, including transportation, warehousing, and distribution of pharmaceuticals, medical devices, and equipment. This market is driven by the need for cost efficiency, regulatory compliance, and the complexity of global supply chains. Advances in cold chain logistics, real-time tracking, and inventory management are pivotal as healthcare demands precision and reliability in delivery.

The Healthcare Third-party Logistics Market is navigating a complex landscape shaped by global tariffs, geopolitical risks, and evolving supply chain dynamics. In Japan and South Korea, firms are increasingly investing in resilient supply chain strategies to mitigate tariff impacts and geopolitical uncertainties. China's focus on self-reliance has intensified, fostering domestic logistics capabilities to reduce dependency on foreign entities. Taiwan's strategic location and expertise in logistics make it pivotal, yet it remains vulnerable to regional tensions. The healthcare logistics sector globally is experiencing robust growth, driven by technological advancements and increased demand for efficient healthcare delivery. By 2035, the market is expected to evolve with a focus on digital integration and sustainability. Middle East conflicts are exerting pressure on global energy prices, indirectly affecting logistics costs and operational stability.

Market Segmentation
TypeCold Chain Logistics, Non-Cold Chain Logistics
ProductPharmaceuticals, Medical Devices, Biologics, Vaccines, Clinical Trial Materials, Over-the-Counter Drugs, Nutraceuticals
ServicesTransportation, Warehousing, Inventory Management, Order Fulfillment, Packaging, Customs Brokerage, Reverse Logistics
TechnologyAutomated Storage and Retrieval Systems, Warehouse Management Systems, Transportation Management Systems, Blockchain, IoT, AI and Machine Learning, Robotics
ComponentHardware, Software, Services
ApplicationHospitals, Pharmaceutical Companies, Biopharmaceutical Companies, Clinical Research Organizations
DeploymentOn-Premise, Cloud-Based, Hybrid
End UserHealthcare Providers, Pharmaceutical Manufacturers, Biotechnology Companies, Logistics Companies
SolutionsSupply Chain Optimization, Inventory Visibility, Risk Management, Compliance Management

The Healthcare Third-party Logistics Market is experiencing significant growth, driven by the rising demand for efficient supply chain solutions in the healthcare sector. The transportation services segment leads in performance, with temperature-controlled logistics and specialized freight services being critical for maintaining product integrity. Within this segment, cold chain logistics is particularly prominent due to the increasing need for biologics and vaccines.

The warehousing and storage segment follows closely, highlighting the importance of secure and compliant facilities for healthcare products. Advanced warehousing solutions, including automated storage and retrieval systems, are gaining traction as they enhance operational efficiency. Value-added services, such as packaging, labeling, and inventory management, are also emerging as essential components, reflecting the market's shift towards comprehensive logistics solutions.

The integration of digital technologies, such as IoT and blockchain, is transforming logistics operations, providing real-time tracking and enhancing transparency. This technological advancement is expected to further propel market growth.

The Healthcare Third-party Logistics Market is witnessing dynamic shifts in market share, with major players vying for dominance through strategic pricing and innovative product launches. The market's competitive landscape is characterized by a focus on cost-efficiency and enhanced service delivery. Companies are continuously launching new products, which are designed to meet the evolving needs of healthcare providers. This trend is a response to the increasing demand for streamlined logistics solutions that ensure the timely and safe delivery of medical products. The pricing strategies employed by these companies are critical in maintaining their competitive edge.

Competition benchmarking reveals a highly competitive environment, with key players enhancing their capabilities through mergers and acquisitions. Regulatory influences play a significant role, as compliance with stringent healthcare regulations is mandatory. This compliance impacts operational strategies and market entry for new players. Data-driven insights highlight a growing trend towards digital transformation in logistics, with technology adoption being a key differentiator. The market is poised for growth, driven by innovations in supply chain management and the integration of advanced technologies such as IoT and AI.

Geographical Overview:

The Healthcare Third-party Logistics (3PL) market is witnessing remarkable growth across various regions, each offering unique opportunities. North America remains a dominant player, propelled by advanced healthcare infrastructure and a robust supply chain network. The region's emphasis on efficient logistics solutions and regulatory compliance further accelerates market expansion.

In Europe, the market is thriving due to increased demand for specialized logistics services, particularly in pharmaceutical and biotechnology sectors. The region's focus on sustainability and innovation enhances its competitive edge. Asia Pacific emerges as a lucrative growth pocket, driven by rapid urbanization and rising healthcare investments.

Countries like China and India are at the forefront, with expanding healthcare facilities necessitating efficient logistics support. Latin America and the Middle East & Africa are also showing promising potential. Brazil and South Africa lead these regions, with growing healthcare needs and improving infrastructure contributing to market growth. These emerging markets offer significant opportunities for investment and expansion.

Recent Developments:

The healthcare third-party logistics market has been dynamic with significant developments over the past three months. DHL Supply Chain, a leader in logistics, announced a strategic partnership with a prominent pharmaceutical company to enhance its cold chain logistics capabilities, ensuring the safe and efficient transport of temperature-sensitive products.

UPS Healthcare expanded its logistics network by acquiring a state-of-the-art facility in the Netherlands, aimed at bolstering its European footprint and improving service delivery for healthcare clients. This acquisition is set to streamline operations and cater to the increasing demand for healthcare logistics in the region.

FedEx has introduced an innovative tracking technology for its healthcare logistics services, enhancing visibility and security for sensitive shipments. This technology aims to mitigate risks and ensure compliance with stringent regulatory standards in the healthcare sector.

In a move to strengthen its market position, Kuehne+Nagel formed a joint venture with a leading digital health company to integrate digital solutions into its logistics operations, offering clients enhanced data analytics and operational efficiency.

The healthcare logistics market witnessed a regulatory update with the European Union implementing new guidelines for the transportation of medical supplies, emphasizing the need for compliance with temperature control and documentation standards, which is expected to impact logistics providers across the continent.

Key Trends and Drivers:

The Healthcare Third-party Logistics Market is experiencing robust growth, driven by the increasing complexity of supply chains and the globalization of healthcare services. A significant trend is the rising demand for temperature-controlled logistics, essential for preserving the efficacy of pharmaceuticals and biologics. This trend underscores the importance of advanced cold chain solutions, ensuring product integrity from production to the point of use.

Moreover, technological advancements, such as IoT and blockchain, are transforming logistics operations, enhancing transparency and traceability. These innovations facilitate real-time monitoring, reducing the risk of counterfeiting and non-compliance. Another driver is the growing emphasis on cost efficiency and operational optimization. Healthcare providers are increasingly outsourcing logistics to third-party experts to focus on core competencies and improve patient care.

Furthermore, regulatory complexities in different regions necessitate specialized logistics solutions, prompting companies to seek third-party logistics partners with global expertise. The rise of e-commerce in healthcare is also a key trend, with consumers expecting faster delivery of medical supplies and devices. Opportunities abound for logistics providers offering integrated services, capable of navigating the multifaceted demands of the healthcare industry. As the market evolves, companies that innovate and adapt to these trends will secure a competitive advantage.

Restraints and Challenges:

The Healthcare Third-party Logistics Market encounters several significant restraints and challenges. A primary challenge is the stringent regulatory environment, which requires compliance with diverse international standards and can complicate operations. Additionally, the high costs associated with maintaining cold chain logistics for temperature-sensitive pharmaceuticals pose financial burdens on third-party logistics providers. Moreover, the market is constrained by the scarcity of skilled workforce capable of managing complex healthcare logistics efficiently. Another challenge is the increasing cybersecurity threats, which jeopardize the integrity and confidentiality of sensitive healthcare data. Lastly, the evolving landscape of healthcare technologies necessitates continuous adaptation and investment, which can strain resources and impede swift market responses. These factors collectively create substantial barriers, impacting the market's growth potential and operational efficiency.

Key Companies:

Kuehne Nagel, DHL Supply Chain, CEVA Logistics, UPS Healthcare, DB Schenker, GEODIS, FedEx Supply Chain, Nippon Express, Agility Logistics, Panalpina, Expeditors International, XPO Logistics, Sinotrans, DSV, Yusen Logistics, Rhenus Logistics, Bollore Logistics, Kintetsu World Express, Hellmann Worldwide Logistics, GEFCO

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Deployment
  • 2.8 Key Market Highlights by End User
  • 2.9 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Cold Chain Logistics
    • 4.1.2 Non-Cold Chain Logistics
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Pharmaceuticals
    • 4.2.2 Medical Devices
    • 4.2.3 Biologics
    • 4.2.4 Vaccines
    • 4.2.5 Clinical Trial Materials
    • 4.2.6 Over-the-Counter Drugs
    • 4.2.7 Nutraceuticals
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Transportation
    • 4.3.2 Warehousing
    • 4.3.3 Inventory Management
    • 4.3.4 Order Fulfillment
    • 4.3.5 Packaging
    • 4.3.6 Customs Brokerage
    • 4.3.7 Reverse Logistics
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Automated Storage and Retrieval Systems
    • 4.4.2 Warehouse Management Systems
    • 4.4.3 Transportation Management Systems
    • 4.4.4 Blockchain
    • 4.4.5 IoT
    • 4.4.6 AI and Machine Learning
    • 4.4.7 Robotics
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Hardware
    • 4.5.2 Software
    • 4.5.3 Services
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Pharmaceutical Companies
    • 4.6.3 Biopharmaceutical Companies
    • 4.6.4 Clinical Research Organizations
  • 4.7 Market Size & Forecast by Deployment (2020-2035)
    • 4.7.1 On-Premise
    • 4.7.2 Cloud-Based
    • 4.7.3 Hybrid
  • 4.8 Market Size & Forecast by End User (2020-2035)
    • 4.8.1 Healthcare Providers
    • 4.8.2 Pharmaceutical Manufacturers
    • 4.8.3 Biotechnology Companies
    • 4.8.4 Logistics Companies
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Supply Chain Optimization
    • 4.9.2 Inventory Visibility
    • 4.9.3 Risk Management
    • 4.9.4 Compliance Management

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Deployment
      • 5.2.1.8 End User
      • 5.2.1.9 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Deployment
      • 5.2.2.8 End User
      • 5.2.2.9 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Deployment
      • 5.2.3.8 End User
      • 5.2.3.9 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Deployment
      • 5.3.1.8 End User
      • 5.3.1.9 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Deployment
      • 5.3.2.8 End User
      • 5.3.2.9 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Deployment
      • 5.3.3.8 End User
      • 5.3.3.9 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Deployment
      • 5.4.1.8 End User
      • 5.4.1.9 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Deployment
      • 5.4.2.8 End User
      • 5.4.2.9 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Deployment
      • 5.4.3.8 End User
      • 5.4.3.9 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Deployment
      • 5.4.4.8 End User
      • 5.4.4.9 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Deployment
      • 5.4.5.8 End User
      • 5.4.5.9 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Deployment
      • 5.4.6.8 End User
      • 5.4.6.9 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Deployment
      • 5.4.7.8 End User
      • 5.4.7.9 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Deployment
      • 5.5.1.8 End User
      • 5.5.1.9 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Deployment
      • 5.5.2.8 End User
      • 5.5.2.9 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Deployment
      • 5.5.3.8 End User
      • 5.5.3.9 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Deployment
      • 5.5.4.8 End User
      • 5.5.4.9 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Deployment
      • 5.5.5.8 End User
      • 5.5.5.9 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Deployment
      • 5.5.6.8 End User
      • 5.5.6.9 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Deployment
      • 5.6.1.8 End User
      • 5.6.1.9 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Deployment
      • 5.6.2.8 End User
      • 5.6.2.9 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Deployment
      • 5.6.3.8 End User
      • 5.6.3.9 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Deployment
      • 5.6.4.8 End User
      • 5.6.4.9 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Deployment
      • 5.6.5.8 End User
      • 5.6.5.9 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Kuehne Nagel
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 DHL Supply Chain
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 CEVA Logistics
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 UPS Healthcare
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 DB Schenker
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 GEODIS
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 FedEx Supply Chain
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Nippon Express
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Agility Logistics
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Panalpina
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Expeditors International
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 XPO Logistics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Sinotrans
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 DSV
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Yusen Logistics
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Rhenus Logistics
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Bollore Logistics
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Kintetsu World Express
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Hellmann Worldwide Logistics
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 GEFCO
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us